These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8261301)

  • 1. Superficial bladder cancer: timing of check cystoscopies in the first year.
    Morris SB; Shearer RJ; Gordon EM; Woodhouse CR
    Br J Urol; 1993 Oct; 72(4):446-8. PubMed ID: 8261301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ta T1 low and intermediate transitional cell carcinoma of the bladder: recurrence rates and the timing of check cystoscopies within the first year.
    Guney S; Guney N; Canogullari Z; Ergenekon E
    Urol Int; 2008; 80(2):124-8. PubMed ID: 18362479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic efficacy of the combination of urine cytology, urine analysis and history in the follow-up of bladder carcinoma.
    Meuleman EJ; Delaere KP
    Br J Urol; 1988 Aug; 62(2):150-3. PubMed ID: 3408887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party).
    Tolley DA; Hargreave TB; Smith PH; Williams JL; Grigor KM; Parmar MK; Freedman LS; Uscinska BM
    Br Med J (Clin Res Ed); 1988 Jun; 296(6639):1759-61. PubMed ID: 3136828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proposal for changes in cystoscopic follow-up of patients with low-grade pTa bladder tumor.
    Oge O; Erdem E; Atsü N; ahin A; Ozen H
    Eur Urol; 2000 Mar; 37(3):271-4. PubMed ID: 10720851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A surveillance schedule for G1Ta bladder cancer allowing efficient use of check cystoscopy and safe discharge at 5 years based on a 25-year prospective database.
    Mariappan P; Smith G
    J Urol; 2005 Apr; 173(4):1108-11. PubMed ID: 15758711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion-weighted magnetic resonance imaging in follow-up of superficial urinary bladder carcinoma after transurethral resection: initial experience.
    El-Assmy A; Abou-El-Ghar ME; Refaie HF; Mosbah A; El-Diasty T
    BJU Int; 2012 Dec; 110(11 Pt B):E622-7. PubMed ID: 22757606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Diagnostic and Prognostic Performance of Urinary FGFR3 Mutation Analysis in Bladder Cancer Surveillance: A Prospective Multicenter Study.
    Couffignal C; Desgrandchamps F; Mongiat-Artus P; Ravery V; Ouzaid I; Roupret M; Phe V; Ciofu C; Tubach F; Mentre F; Cussenot O; Grandchamp B
    Urology; 2015 Dec; 86(6):1185-90. PubMed ID: 26364695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fluorescence cystoscopy in the diagnostics and treatment of superficial urinary bladder tumors].
    Babjuk M; Soukup V; Petrík R; Pavlík I; Jirsa M; Dvorácek J; Pecen L
    Cas Lek Cesk; 2005; 144 Suppl 2():15-8. PubMed ID: 16277179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-aminolaevulinic acid-induced fluorescence cystoscopy during transurethral resection reduces the risk of recurrence in stage Ta/T1 bladder cancer.
    Babjuk M; Soukup V; Petrík R; Jirsa M; Dvorácek J
    BJU Int; 2005 Oct; 96(6):798-802. PubMed ID: 16153204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
    Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
    Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective analysis of transurethral resection, second-look resection, and long-term chemo-metaphylaxis for superficial bladder cancer: indications and efficacy of a differentiated approach.
    Schulze M; Stotz N; Rassweiler J
    J Endourol; 2007 Dec; 21(12):1533-41. PubMed ID: 18186695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can efficiency of follow-up for superficial bladder cancer be increased?
    Gulliford MC; Petruckevitch A; Burney PG
    Ann R Coll Surg Engl; 1993 Jan; 75(1):57-61. PubMed ID: 8422147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recurrent transitional cell carcinoma of the bladder in a young woman: report of a case].
    Ikeda I; Terao T; Nakagomi K; Masuda M; Hirokawa M
    Hinyokika Kiyo; 1992 Nov; 38(11):1261-3. PubMed ID: 1485578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follow-up of patients with "superficial" transitional cell carcinoma of the bladder: the case for a change in policy.
    Abel PD
    Br J Urol; 1993 Aug; 72(2):135-42. PubMed ID: 8402013
    [No Abstract]   [Full Text] [Related]  

  • 16. [After-care of bladder carcinoma].
    Retz M; Lehmann J; Wullich B; Stöckle M
    Urologe A; 2001 Nov; 40(6):480-4. PubMed ID: 11760356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flexible cystoscopy and Holmium:Yttrium aluminum garnet laser ablation for recurrent nonmuscle invasive bladder carcinoma under local anesthesia.
    Syed HA; Talbot N; Abbas A; MacDonald D; Jones R; Marr TJ; Rukin NJ
    J Endourol; 2013 Jul; 27(7):886-91. PubMed ID: 23537221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transitional cell carcinoma of the bladder in first decade of life.
    Patel R; Tery T; Ninan GK
    Pediatr Surg Int; 2008 Nov; 24(11):1265-8. PubMed ID: 18813937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of intravesical thiotepa on tumour recurrence after endoscopic treatment of newly diagnosed superficial bladder cancer. A further report with long-term follow-up of a Medical Research Council randomized trial. Medical Research Council Working Party on Urological Cancer, Subgroup on Superficial Bladder Cancer.
    Br J Urol; 1994 Jun; 73(6):632-8. PubMed ID: 8032829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can transabdominal ultrasonography of the bladder replace cystoscopy in the followup of superficial bladder tumors?
    Vallancien G; Veillon B; Charton M; Brisset JM
    J Urol; 1986 Jul; 136(1):32-4. PubMed ID: 3520026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.